At AbbVie, our life’s work is to improve lives, and we pledge to do so in a transparent and sustainable way.
We support public policies that promote our mission of:
Read the guiding principles, policies and governance structures that shape our ethical culture.
We follow the Innovative Medicine Canada (IMC) Code of ethical practices. Visit section 3.3 - Guidelines for transparency in funding of patient and advocacy groups and patient associations (including annex A) from the 2022 Code of Ethical Practices document listed on the Innovative Medicines Canada website.
The objective of the Voluntary Disclosure of Payments initiative is to increase transparency about our operations in Canada and in doing so, increase trust with stakeholders within our healthcare system.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.